Company / EPS (Diluted)
TransMedics Group, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.77
FY2025
5-year range
-$1.60 / -$0.77
FY2021-FY2025
Trend
+37.4%
vs FY2024
Sector context
#118 of 159
Health Care
What the data says
At $-0.77, TransMedics Group, Inc.'s eps (diluted) ranks #118 of 159 in the Health Care sector. Improved from $-1.60 to $-0.77 over the past 2 years.
Based on SEC 10-K filings.
-0.77 in FY2025.
Improved from $-1.60 to $-0.77 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#118 of 159 in Health CareTop 74% of 159This company -$0.77 Sector average $1.66
▼
-146.5% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 37.4% year-over-year.
- Ranks #118 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2019.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.77 | +37.4% |
| FY2024 | -$1.23 | +23.1% |
| FY2023 | -$1.60 | -37.9% |
| FY2022 | -$1.16 | +0.0% |
| FY2021 | -$1.16 | +50.8% |
| FY2020 | -$2.36 | +71.4% |
| FY2019 | -$8.24 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026